Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, Michigan, USA.
Craig H Neilsen Foundation, Encino, California, USA.
J Spinal Cord Med. 2020 Mar;43(2):141-164. doi: 10.1080/10790268.2019.1706033.
To provide an overview of clinical assessments and diagnostic tools, self-report measures (SRMs) and data sets used in neurogenic bladder and bowel (NBB) dysfunction and recommendations for their use with persons with spinal cord injury /disease (SCI/D). Experts in SCI/D conducted literature reviews, compiled a list of NBB related assessments and measures, reviewed their psychometric properties, discussed their use in SCI/D and issued recommendations for the National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) Common Data Elements (CDEs) guidelines. Clinical assessments included 15 objective tests and diagnostic tools for neurogenic bladder and 12 for neurogenic bowel. Following a two-phase evaluation, eight SRMs were selected for final review with the Qualiveen and Short-Form (SF) Qualiveen and the Neurogenic Bowel Dysfunction Score (NBDS) being recommended as supplemental, highly-recommended due to their strong psychometrics and extensive use in SCI/D. Two datasets and other SRM measures were recommended as supplemental. There is no one single measure that can be used to assess NBB dysfunction across all clinical research studies. Clinical and diagnostic tools are here recommended based on specific medical needs of the person with SCI/D. Following the CDE for SCI studies guidelines, we recommend both the SF-Qualiveen for bladder and the NBDS for bowel as relatively short measures with strong psychometrics. Other measures are also recommended. A combination of assessment tools (objective and subjective) to be used jointly across the spectrum of care seems critical to best capture changes related to NBB and develop better treatments.
提供神经原性膀胱和肠道(NBB)功能障碍的临床评估和诊断工具、自我报告测量(SRM)和数据集的概述,并为脊髓损伤/疾病(SCI/D)患者推荐其使用方法。SCI/D 专家进行了文献回顾,编制了 NBB 相关评估和测量清单,审查了其心理测量特性,讨论了它们在 SCI/D 中的使用,并为美国国立卫生研究院(NIH)、国家神经疾病和中风研究所(NINDS)发布了共同数据元素(CDE)指南的建议。临床评估包括 15 种用于神经原性膀胱的客观测试和诊断工具,以及 12 种用于神经原性肠道的测试和诊断工具。经过两阶段评估,选择了 8 种 SRM 进行最终审查,推荐使用 Qualiveen 和 Short-Form(SF)Qualiveen 以及神经原性肠道功能障碍评分(NBDS)作为补充,由于其强大的心理测量学特性和在 SCI/D 中的广泛应用,强烈推荐这两种作为补充。还推荐了两个数据集和其他 SRM 测量作为补充。没有一种单一的测量方法可以在所有临床研究中评估 NBB 功能障碍。根据 SCI/D 患者的特定医疗需求,推荐使用临床和诊断工具。我们遵循 SCI 研究 CDE 指南,建议将 SF-Qualiveen 用于膀胱和 NBDS 用于肠道,因为它们是具有强大心理测量学特性的相对简短的测量方法。还推荐了其他措施。在整个护理范围内联合使用评估工具(客观和主观)似乎对于最佳捕捉与 NBB 相关的变化和开发更好的治疗方法至关重要。